CROSSROADS STRATEGIES, LLC

Lobbying for NOVAVAX, INC. · biotechnology company

Filing 2nd Quarter - Termination

2nd Quarter (Apr 1 - June 30) 2025 · Maryland · House · Senate · $20,000.00 income · posted Jul 20, 2025

Lobbying activity 3

Health Issues

Issues related to COVID-19 vaccines.

Budget/Appropriations

FY2025 Budget Reconciliation Process; all bio-pharmaceutical related provisions.

Trade (domestic/foreign)

Issues related to tariffs.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.